At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
2500 ppm Carbon Dioxide +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Carbon Dioxide (CO2): A Pilot Study of a Hypothesized Mechanism to Explain Cognitive Impairment
In Brief
A clinical study evaluating 2500 ppm Carbon Dioxide and 600 ppm Carbon Dioxide for Healthy. Completed, enrolled 27 participants across 1 site.
Detailed Summary
The purpose of the study is to better understand the biological mechanisms of carbon dioxide (CO2)-induced cognitive impairments.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedMar 2022
Enrollment StartJul 2022
Primary CompletionMar 2025
TodayJul 2026
First PostedMar 23, 2022
Enrollment StartJul 14, 2022
Primary CompletionMar 20, 2025
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 4.3 years ago
Interventions
2500 ppm Carbon Dioxideother
2.5 hour exposure to 2500 ppm carbon dioxide
600 ppm Carbon Dioxideother
2.5 hour exposure to 600 ppm carbon dioxide